RealTimeImage
A provider of Internet-based imaging products, RealTimeImage offers streaming-based technology that delivers data-intensive images losslessly over network connections or the Internet. Its iPACS platform is the centerpiece of the Web-based product line.
A provider of Internet-based imaging products, RealTimeImage offers streaming-based technology that delivers data-intensive images losslessly over network connections or the Internet. Its iPACS platform is the centerpiece of the Web-based product line.
- Enhancements include streaming-based 3D review, improved overlay presentation and editing, extended measurement tools, support for multihead and high-resolution display, and support for DICOM printers.
- InDex Web, a real-time, secure, Web-based solution, debuted as a joint product between RealTimeImage and InSiteOne. Using RealTimeImage's iPACS Web-based image streaming capability, InDex Web enables 24-hour secure access to images archived at InSiteOne's permanent data storage centers using Internet or network connections. Images are accessible in real-time in increasing levels of resolution to speed transfer over any bandwidth.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
